LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis

X-Y Na1, X-Q Hu, Y Zhao

  • 1Department of Neurology, People's Hospital of Zhenhai District, Ningbo, China. shangxs320@163.com.

Abstract

Insights

Long noncoding RNA DNAJC3-AS1 is upregulated in clear cell renal cell carcinoma (ccRCC). Silencing this lncRNA inhibits ccRCC progression by affecting cell proliferation, migration, invasion, and apoptosis via the miR-27a-3p/PRDM14 pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Renal cell carcinoma (RCC) is a prevalent urological malignancy with unsatisfactory prognosis despite diagnostic and therapeutic advancements.
  • Long noncoding RNAs (lncRNAs) are increasingly recognized for their critical roles in cancer initiation and progression.
  • Clear cell renal cell carcinoma (ccRCC) is the most common subtype of RCC, necessitating further understanding of its underlying molecular mechanisms.

Purpose of the Study:

  • To investigate the expression and functional significance of lncRNA DNAJC3-AS1 in the tumorigenesis of ccRCC.
  • To elucidate the molecular interactions involving DNAJC3-AS1, microRNA-27a-3p (miR-27a-3p), and PR domain containing 14 (PRDM14) in ccRCC.

Main Methods:

  • Quantitative real-time PCR (RT-PCR) to assess DNAJC3-AS1 expression in ccRCC tissues and cell lines.
  • In vitro experiments involving silencing DNAJC3-AS1 to evaluate its effects on ccRCC cell proliferation, migration, invasion, and apoptosis.
  • Dual-luciferase reporter assays to confirm the interaction between DNAJC3-AS1, miR-27a-3p, and PRDM14.
  • Western blotting to measure protein expression levels.

Main Results:

  • DNAJC3-AS1 expression was significantly upregulated in ccRCC tissues and cell lines compared to normal controls.
  • Silencing DNAJC3-AS1 inhibited ccRCC cell proliferation, migration, and invasion, while promoting apoptosis.
  • DNAJC3-AS1 functions as a molecular sponge for miR-27a-3p, and PRDM14 was identified as a downstream target of miR-27a-3p.

Conclusions:

  • LncRNA DNAJC3-AS1 acts as an oncogene in ccRCC development.
  • The oncogenic role of DNAJC3-AS1 in ccRCC is mediated through the regulation of the miR-27a-3p/PRDM14 axis.
  • Targeting the DNAJC3-AS1/miR-27a-3p/PRDM14 pathway may offer a novel therapeutic strategy for ccRCC.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K